{"success":true,"data":{"pressRelease":{"id":"165093","rtpr_id":"nPreg7WGNa-20261009","ticker":"HIGHG","exchange":"XETRA","all_tickers":["HIGHG"],"title":"Cantourage and Green Karat deepen strategic partnership following EU-GMP certification","author":"PR Newswire","published_at":"2026-10-09T06:50:34.352Z","article_body":"Cantourage and Green Karat deepen strategic partnership following EU-GMP\ncertification\nPR Newswire\n\nBERLIN, Oct. 9, 2026\n* Exclusive product access: Cantourage strengthens its premium portfolio\nacross Europe and reinforces its role as a gateway to European markets for\nCanadian producers.\n* Greater supply-chain resilience: Direct imports of EU-GMP-certified finished\nproducts increase flexibility and strengthen supply-chain resilience.\n* Additional manufacturing capacity: Shifting production steps to certified\ncultivation partners creates additional capacity.\nBERLIN, Oct. 9, 2026 /PRNewswire/ -- Cantourage Group SE (ISIN: DE000A3DSV01)\nis strengthening its position as a leading European platform for medical\ncannabis. Its long-standing Canadian partner Green Karat obtained EU-GMP\ncertification effective 1 October 2026. Cantourage supported the certification\nprocess as sponsor and certification partner and is Green Karat's exclusive\ndistribution partner for products manufactured by Green Karat in the European\nUnion and the United Kingdom.\n\nThe certification marks an important step in Cantourage's strategy of helping\nleading international cannabis producers access the European market while\nsecuring attractive products and brands for its core European markets through\nexclusive partnerships.\n\nThe partnership between Cantourage and Green Karat is built on a long-standing\nrelationship of trust. EU-GMP certification takes the collaboration to the\nnext level: Cantourage will be able to import finished products manufactured\nby Green Karat directly from Canada in accordance with EU-GMP standards. This\ncan help make products available to pharmacies across Europe sooner after\nharvest.\n\n\"Cantourage has been an important and trusted partner for us in Europe for\nmany years. The company combines deep regulatory expertise with strong access\nto the European markets that matter to us and a clear understanding of\nhigh-quality cannabis products. Working with Cantourage on the EU-GMP\ncertification process was therefore a natural next step. The certification\ncreates the basis for bringing our products to patients in Europe more\ndirectly and quickly, and for continuing to grow our presence across Europe\ntogether,\" said Jen-Frederick Nadeau, founder and CEO of Green Karat.\n\n\"Green Karat has been a trusted partner for many years, and this certification\nmarks an important next step in our collaboration. By supporting our partners\nthrough EU-GMP certification, we are building a more flexible and resilient\nsupply chain and strengthening access to high-quality products for patients\nand customers across Europe,\" said Philip Schetter, CEO of Cantourage Group\nSE.\n\nAt the same time, the model offers Cantourage tangible strategic and\noperational benefits. Shifting production steps to EU-GMP-certified\ncultivation partners gives Cantourage greater flexibility across its value\nchain and opens up additional manufacturing capacity. A broader production\nfootprint also reduces operational concentration risk and strengthens\nsupply-chain resilience. This positions Cantourage to expand its business with\npremium products from international partners efficiently and at scale.\n\nGreen Karat is one example of Cantourage's broader certification strategy.\nCantourage is already working with other leading international producers on\ncertification processes, which are expected to be completed by the end of\n2026. The company is continuing to strengthen its role as a certification\npartner and as a gateway to the European market for Canadian and other\ninternational cannabis producers.\n\nFor Cantourage, the combination of exclusive partnerships, regulatory\nexpertise and an international network of high-quality producers is a key\npillar of its European growth strategy. The company intends to further develop\nits role as a link between leading international cannabis producers and\nEuropean markets.\n\nMedia Contact:\ninfo@cantourage.com\n\nAbout Cantourage\n\nCantourage is a leading European company engaged in the production and\ndistribution of medical cannabis preparations and cannabis-based\npharmaceuticals. With an experienced management team and its \"Fast Track\nAccess\" platform, Cantourage enables producers from around the world to access\nthe growing European medical cannabis market faster, more easily and more\ncost-effectively by processing and distributing their cannabis raw materials\nand extracts. In doing so, Cantourage consistently ensures compliance with the\nhighest European pharmaceutical quality standards.\n\nThe Company offers pharmaceutical-grade products across all relevant market\nsegments: dried flower, extracts, dronabinol and cannabidiol. Cantourage was\nlisted on the Frankfurt Stock Exchange on 11 November 2022 – DE000A3DSV01\n(ISIN).\n\n \n\nView original\ncontent:https://www.prnewswire.co.uk/news-releases/cantourage-and-green-karat-deepen-strategic-partnership-following-eu-gmp-certification-302903344.html\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPreg7WGNa-20261009","title":"Cantourage and Green Karat deepen strategic partnership following EU-GMP certification","author":"PR Newswire","ticker":"HIGHG","created":"2026-10-09T06:50:34.352Z","tickers":["HIGHG"],"exchange":"XETRA","article_body":"Cantourage and Green Karat deepen strategic partnership following EU-GMP\ncertification\nPR Newswire\n\nBERLIN, Oct. 9, 2026\n* Exclusive product access: Cantourage strengthens its premium portfolio\nacross Europe and reinforces its role as a gateway to European markets for\nCanadian producers.\n* Greater supply-chain resilience: Direct imports of EU-GMP-certified finished\nproducts increase flexibility and strengthen supply-chain resilience.\n* Additional manufacturing capacity: Shifting production steps to certified\ncultivation partners creates additional capacity.\nBERLIN, Oct. 9, 2026 /PRNewswire/ -- Cantourage Group SE (ISIN: DE000A3DSV01)\nis strengthening its position as a leading European platform for medical\ncannabis. Its long-standing Canadian partner Green Karat obtained EU-GMP\ncertification effective 1 October 2026. Cantourage supported the certification\nprocess as sponsor and certification partner and is Green Karat's exclusive\ndistribution partner for products manufactured by Green Karat in the European\nUnion and the United Kingdom.\n\nThe certification marks an important step in Cantourage's strategy of helping\nleading international cannabis producers access the European market while\nsecuring attractive products and brands for its core European markets through\nexclusive partnerships.\n\nThe partnership between Cantourage and Green Karat is built on a long-standing\nrelationship of trust. EU-GMP certification takes the collaboration to the\nnext level: Cantourage will be able to import finished products manufactured\nby Green Karat directly from Canada in accordance with EU-GMP standards. This\ncan help make products available to pharmacies across Europe sooner after\nharvest.\n\n\"Cantourage has been an important and trusted partner for us in Europe for\nmany years. The company combines deep regulatory expertise with strong access\nto the European markets that matter to us and a clear understanding of\nhigh-quality cannabis products. Working with Cantourage on the EU-GMP\ncertification process was therefore a natural next step. The certification\ncreates the basis for bringing our products to patients in Europe more\ndirectly and quickly, and for continuing to grow our presence across Europe\ntogether,\" said Jen-Frederick Nadeau, founder and CEO of Green Karat.\n\n\"Green Karat has been a trusted partner for many years, and this certification\nmarks an important next step in our collaboration. By supporting our partners\nthrough EU-GMP certification, we are building a more flexible and resilient\nsupply chain and strengthening access to high-quality products for patients\nand customers across Europe,\" said Philip Schetter, CEO of Cantourage Group\nSE.\n\nAt the same time, the model offers Cantourage tangible strategic and\noperational benefits. Shifting production steps to EU-GMP-certified\ncultivation partners gives Cantourage greater flexibility across its value\nchain and opens up additional manufacturing capacity. A broader production\nfootprint also reduces operational concentration risk and strengthens\nsupply-chain resilience. This positions Cantourage to expand its business with\npremium products from international partners efficiently and at scale.\n\nGreen Karat is one example of Cantourage's broader certification strategy.\nCantourage is already working with other leading international producers on\ncertification processes, which are expected to be completed by the end of\n2026. The company is continuing to strengthen its role as a certification\npartner and as a gateway to the European market for Canadian and other\ninternational cannabis producers.\n\nFor Cantourage, the combination of exclusive partnerships, regulatory\nexpertise and an international network of high-quality producers is a key\npillar of its European growth strategy. The company intends to further develop\nits role as a link between leading international cannabis producers and\nEuropean markets.\n\nMedia Contact:\ninfo@cantourage.com\n\nAbout Cantourage\n\nCantourage is a leading European company engaged in the production and\ndistribution of medical cannabis preparations and cannabis-based\npharmaceuticals. With an experienced management team and its \"Fast Track\nAccess\" platform, Cantourage enables producers from around the world to access\nthe growing European medical cannabis market faster, more easily and more\ncost-effectively by processing and distributing their cannabis raw materials\nand extracts. In doing so, Cantourage consistently ensures compliance with the\nhighest European pharmaceutical quality standards.\n\nThe Company offers pharmaceutical-grade products across all relevant market\nsegments: dried flower, extracts, dronabinol and cannabidiol. Cantourage was\nlisted on the Frankfurt Stock Exchange on 11 November 2022 – DE000A3DSV01\n(ISIN).\n\n \n\nView original\ncontent:https://www.prnewswire.co.uk/news-releases/cantourage-and-green-karat-deepen-strategic-partnership-following-eu-gmp-certification-302903344.html\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-09T06:50:34.400915192Z","server_sent_at_ms":1791528634400},"received_at":"2026-10-09T06:50:34.451Z","source_url":null},"analysis":{"id":"153493","press_release_id":"165093","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"partnership","narrative":"Cantourage Group SE announced that its long-standing Canadian partner Green Karat obtained EU-GMP certification effective 1 October 2026, with Cantourage as sponsor of the process and exclusive distributor of Green Karat products in the EU and UK.\n\nDirect imports of EU-GMP-certified finished products from Canada are expected to speed availability to European pharmacies, add manufacturing capacity, and reduce supply-chain concentration risk.\n\nCantourage says it is working with other international producers on certifications expected to complete by end of 2026, reinforcing its gateway-to-Europe strategy, though no financial figures were disclosed.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"EU-GMP certification of Canadian partner Green Karat deepens Cantourage's exclusive-distribution moat in European medical cannabis."},"keyFigures":{"customDimensions":{"certification_effective_date":"1 October 2026","expected_completion_of_other_certifications":"end of 2026"}},"quotedText":"By supporting our partners through EU-GMP certification, we are building a more flexible and resilient supply chain and strengthening access to high-quality products for patients and customers across Europe","namedEntities":{"people":[{"name":"Philip Schetter","role":"CEO of Cantourage Group SE"},{"name":"Jen-Frederick Nadeau","role":"founder and CEO of Green Karat"}],"products":["dried flower","extracts","dronabinol","cannabidiol","Fast Track Access platform"],"companies":[{"name":"Cantourage Group SE","ticker":"HIGHG","relationship":"filer / exclusive distribution partner"},{"name":"Green Karat","relationship":"Canadian cultivation partner"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Positive strategic development — partner Green Karat obtained EU-GMP certification with Cantourage as exclusive EU/UK distributor — but no revenue figures, contract values, or timelines with financial impact are disclosed. Incremental progress on an existing strategy."},"tickerRelevance":{"others":[],"primary":"HIGHG"},"globalImportance":20,"audienceRelevance":15,"eventTypeSecondary":["operations_update"],"importanceComponents":{"tickerTier":"micro-cap / Frankfurt-listed","eventGravity":"strategic partnership deepening, no financial terms","sectorWeight":"cannabis — niche retail interest","issuerAuthored":true}},"event_type":"partnership","event_type_secondary":["operations_update"],"sentiment":"bullish","material_impact_score":2,"narrative":"Cantourage Group SE announced that its long-standing Canadian partner Green Karat obtained EU-GMP certification effective 1 October 2026, with Cantourage as sponsor of the process and exclusive distributor of Green Karat products in the EU and UK.\n\nDirect imports of EU-GMP-certified finished products from Canada are expected to speed availability to European pharmacies, add manufacturing capacity, and reduce supply-chain concentration risk.\n\nCantourage says it is working with other international producers on certifications expected to complete by end of 2026, reinforcing its gateway-to-Europe strategy, though no financial figures were disclosed.","key_figures":{"customDimensions":{"certification_effective_date":"1 October 2026","expected_completion_of_other_certifications":"end of 2026"}},"named_entities":{"people":[{"name":"Philip Schetter","role":"CEO of Cantourage Group SE"},{"name":"Jen-Frederick Nadeau","role":"founder and CEO of Green Karat"}],"products":["dried flower","extracts","dronabinol","cannabidiol","Fast Track Access platform"],"companies":[{"name":"Cantourage Group SE","ticker":"HIGHG","relationship":"filer / exclusive distribution partner"},{"name":"Green Karat","relationship":"Canadian cultivation partner"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-09T06:50:47.622Z","global_importance":20,"audience_relevance":15,"importance_components":{"tickerTier":"micro-cap / Frankfurt-listed","eventGravity":"strategic partnership deepening, no financial terms","sectorWeight":"cannabis — niche retail interest","issuerAuthored":true}},"durationMs":13163,"modelName":"glm-5.3-flashx"}}